NIH
-
April 13, 2017
Vanderbilt University School of Medicine moves to eighth in NIH research funding
Vanderbilt University School of Medicine (VUSM) now ranks No. 8 in the nation among U.S. medical schools in total grant support provided through the National Institutes of Health (NIH). The new ranking raises VUSM’s standing two spots from the No. 10 position it held last year. -
April 13, 2017
Clue to pulmonary hypertension
Vanderbilt investigators have studied the relationship between race, cardiometabolic traits and pulmonary hypertension. -
March 31, 2017
A molecular clue to longevity
In budding yeast, accumulation of a certain type of RNA in the nucleus increased life span, offering a new clue to longevity. -
March 30, 2017
Nanobeacon lights up colon tumors
A novel fluorescent nanobeacon can distinguish normal from diseased colon tissue, potentially offering advantages for colorectal cancer screening. -
March 22, 2017
Blocking neuroblastoma cell growth
An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths. -
March 20, 2017
Delirium in the ED
Interventions for delirium in the emergency department setting are needed to preserve patients’ long-term function and cognition, Vanderbilt investigators have found. -
March 17, 2017
New target for colorectal cancer
Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.